TScan Therapeutics Inc. (TCRX)
2.17
-0.02 (-0.91%)
At close: Feb 21, 2025, 3:59 PM
2.17
-0.23%
After-hours: Feb 21, 2025, 05:36 PM EST
TScan Therapeutics Revenue
TScan Therapeutics reported an annual revenue of $21.05M, reflecting a 55.52% growth. For the quarter ending September 30, 2024, TScan Therapeutics generated $1.05M in revenue.
Revenue (ttm)
$21.05M
Revenue Growth
55.52%
Price / Sales Ratio
18.17
Revenue / Employee
$111.96K
Employees
188
Market Cap
116.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| 2023-12-31 | 21.05M | +55.52% |
| 2022-12-31 | 13.54M | +33.47% |
| 2021-12-31 | 10.14M | +834.65% |
| 2020-12-31 | 1.08M | n/a |